Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Lifecare

Mindre end 1K følgere

LIFE

Oslo Børs

Medical Equipment & Services

Health Care

Oversigt
Investorkonsensus

Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Læs mere
Markedsværdi
-
Aktieomsætning
-
Omsætning
9,67 mio.
EBIT %
-876,63 %
P/E
-
Udbytteafkast, %
-
Finanskalender
19.2
2026

Årsrapport '25

23.4
2026

Generalforsamling '26

14.5
2026

Delårsrapport Q1'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse13.11.2025, 09.28

LIFE: Financial calendar

Lifecare
Selskabsmeddelelse12.11.2025, 19.34

Minutes from Extraordinary General Meeting

Lifecare
Selskabsmeddelelse12.11.2025, 06.00

LIFE: Lifecare ASA Q3 2025 results

Lifecare

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse6.11.2025, 06.00

Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results

Lifecare
Pressemeddelelse5.11.2025, 06.00

Lifecare shares key learnings from ongoing longevity study LFC-SEN-002

Lifecare
Pressemeddelelse28.10.2025, 06.00

Lifecare receives update from NOMA on handling time for first-in-human study application

Lifecare
Selskabsmeddelelse22.10.2025, 12.00

LIFECARE ASA: Extraordinary General Meeting

Lifecare
Pressemeddelelse22.10.2025, 10.50

DNB Carnegie Access: Lifecare ASA: Withdrawing fair value

Lifecare
Selskabsmeddelelse22.10.2025, 05.16

Lifecare ASA: Key information relating to the proposed partially underwritten rights issue

Lifecare
Selskabsmeddelelse22.10.2025, 05.15

Lifecare ASA: Proposed partially underwritten rights issue

Lifecare
Pressemeddelelse24.9.2025, 05.00

Lifecare strengthens miniaturisation roadmap with new patent applications

Lifecare
Pressemeddelelse15.9.2025, 05.00

LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY

Lifecare
Pressemeddelelse27.8.2025, 05.00

Reconfirmed positive results in veterinary study support path toward market entry

Lifecare
Pressemeddelelse20.8.2025, 13.41

DNB Carnegie Access: Lifecare ASA: Progressing well, with financing on the agenda – Q2 review

Lifecare
Selskabsmeddelelse20.8.2025, 05.00

LIFE: Lifecare ASA Q2 2025 results

Lifecare
Pressemeddelelse13.8.2025, 05.47

Lifecare advances CE mark preparation for its groundbreaking medical device

Lifecare
Pressemeddelelse12.8.2025, 12.35

Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST

Lifecare
Pressemeddelelse5.8.2025, 05.00

Lifecare receives ethics approval to initiate first-in-human trial in Norway

Lifecare
Pressemeddelelse8.7.2025, 05.00

Lifecare achieves full radio frequency compliance for CGM implant – clearing the way for CE mark of electronics

Lifecare
Pressemeddelelse1.7.2025, 05.00

Lifecare advances electromagnetic compatibility compliance testing for CGM implant

Lifecare
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.